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ABSTRACT 
Transdermal microneedles have captured the attention of researchers in relation to a variety of 
applications and silicone-based molds required to produce these systems are now widely 
available and can be readily manufactured on the lab bench. The production of nano composite 
microneedle arrays through micro-molding techniques is described. The formulation of nano 
particulate carbon along with pH sensitive cellulose acetate phthalate as a polymeric binder is 
shown to produce conductive microneedles whose swelling/dissolution properties can be 
controlled electrochemically. Through exploiting hydrogen evolution at the microneedle array, 
changes in local pH can induce swelling within the needle structure and could lay the 
foundations for a new approach to the smart device controlled delivery of therapeutic agents. The 
surface modification of the carbon needles with palladium and cysteine is critically assessed 
from sensing and drug delivery perspectives.  
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INTRODUCTION 
Microneedle systems are increasingly being heralded as a technological step change in drug 
delivery applications and can offer a multitude of advantages over conventional syringe based 
approaches 1-9. These microneedle (MN) systems typically comprise an array of sub millimetre 
sized projections (50-900 m) and, in contrast to conventional hypodermic injections, are 
sufficiently small that the shallow penetration depth typically fails to trigger the dermal nerve 
network 9-11. The near painless puncture of the skin barrier allows the transport of a large variety 
of drugs and vaccines to the underlying microcirculation and the success of the general strategy 
has seen a near exponential rise in publications 3. There are generally five classes of MN system: 
solid, coated, hollow, dissolvable and swellable. Each has its own merits and limitations and they 
have been extensively reviewed 1-9. As the development of MN patches has continued apace, 
there has been a trickle-down availability of the technologies required to produce them with 
silicone molds allowing rapid, low cost, soft lithographic production within conventional 
laboratory environments 1,2,12,13. The processes can be adapted for preparing all bar the hollow 
designs. The aim of the present communication has been to investigate the development of 
composite solid microneedles consisting of polymer encapsulated nano carbon. The intention 
was to create electrochemically conductive MN arrays that could, in principle, offer the potential 
for electrochemical techniques to be applied such that the MN patches could possess sensing 
capabilities but, more importantly, could also be used to control drug release. The latter sits at 
the core of the approach as the electronic control over the release mechanism could offer a new 
approach in MN design.  
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The rationale adopted here revolves around the use of cellulose acetate phthalate (CAP) as the 
binding polymer used to maintain the integrity of the needle structure. In contrast to more benign 
polymer systems used in MN manufacture (i.e. polycarbonate or polystyrene 12,13), CAP is pH 
sensitive and is already used in a multitude of oral drug formulations 14-18. The CAP outer layer 
is stable in the acid of the stomach but dissolves upon reaching the alkaline environments of the 
colon 16,17. Exploitation of the pH sensitivity of the polymer for use in electrochemically 
controlled drug release has been described previously but in the context of its use as a film 
encapsulating a drug loaded reservoir 19. The intention here was to use the CAP matrix as the 
binding medium within which nano carbon particles would be mixed to yield a composite 
microneedle but which could swell or dissolve upon changes in local pH brought about by the 
imposition of a suitably reducing potential. The latter relates to the hydrogen evolution reaction 
(HER) whereby there is an increase in local pH at the electrode as a consequence of the 
reduction process 19. It could be envisaged therefore that, were the HER reaction to be imposed 
at the MN array, the increase in local pH would lead to the swelling (and possible dissolution) of 
the CAP polymer that constitutes the needle structure. Thus, were drugs to be entrapped within 
the network at the time of formulation, then the electrochemically induced swelling could allow 
control over their release. The ultimate embodiment of the proposed electrochemically driven 
strategy is highlighted in Figure 1.  There is a burgeoning interest in the use of dissolvable and 
swellable MN systems for drug release 1-9 and, while the formulation process is similar to that 
proposed here, the release process for those is inherently passive. It was therefore of interest to 
determine whether the introduction of the nano carbon particles could facilitate the development 
of a controlled release mechanism and critically evaluate the merits and limitations that such 
systems would present for transdermal drug delivery. 
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Figure 1.  Overview of the proposed electrochemically initiated release mechanism 
MATERIALS AND METHODS 
Electrochemical analysis was performed utilizing a µAutolab Type III computer operated 
potentiostat (Eco-Chemie, Utrecht, The Netherlands). All measurements were conducted at 22oC 
± 2oC. Nano carbon powder was supplied by Sigma Aldrich with a mean particle size of 100 nm. 
Silicone MPatch™ microneedle templates were purchased from Micropoint Technologies Pte 
Ltd. (CleanTech Loop, Singapore). The initial measurements involved a three electrode 
configuration comprising of carbon-polymer composite MN working electrode, a counter 
electrode in the form of a platinum wire and a standard silver/silver chloride (3M NaCl, BAS 
Technicol UK) reference electrode.  
Microneedle Fabrication. Production of the MNs was generally achieved through the simple 
mixing and dispersion of the nano carbon (Sigma-Aldrich) within the polymer (50/50 wt%) that 
had previously been dissolved in a suitable solvent such as cyclohexanone. The silicone molds 
were obtained from Micropoint Technologies and typically comprised of a 10 x 10 MN array. 
The needle dimensions used in the studies were either 200 x 200 x 350 micron or 200 x 200 x 
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700 micron. The molds were cleaned by sonication and the polymer-carbon mixture added and 
the solvent allowed to evaporate. The use of a vacuum oven (under ambient temperature) was 
found to greatly improve the speed of the production process and needle quality through 
accelerating the removal of trapped solvent. In the case of microneedle arrays loaded with 
Toluidine Blue (TBO), the silicone molds were initially coated with carbon-CAP solution to 
yield a coherent but conductive interface. A second mixture of the carbon-CAP containing 1% 
TBO was then introduced and the needles cured as specified previously. 
Microneedle Modification. The nano carbon-CAP microneedles were sputtered with a thin 
layer of Palladium using a 80:20 Pd/Au target at 30mA for 3 minutes (Emitech K500X Sputter 
Coater, Quorum Technologies Ltd, England). X-ray photoelectron spectroscopy (XPS) of the 
Palladium samples before and after modification with cysteine was performed using an Axis 
Ultra DLD spectrometer (Kratos Analytical, Japan) using monochromated Al Ja X-rays (15 kV 
and 10 mA) with an operating pressure lower than 6x10-8 Pa. A hybrid lens mode was used 
during analysis and charge neutralization was achieved using an immersion lens with a filament 
current of between 1.7 and 2.1 mA at a charge balance voltage of between 3.0 and 3.6 V. Three 
spots were analysed per sample and wide energy survey scans (0–1300 eV binding energy) as 
well as high resolution spectra for Pd3d, C1s, N1s and O1s and S2p. Pass-energy was 160 eV for 
the wide energy survey scans and 20 eV for the high resolution spectra.  
Biocompatibility Studies. The biocompatibility of the nano carbon-cellulose acetate 
composite was assessed in relation to skin irritation (DIN EN ISO 10993-10:2014) and 
cytotoxicity (DIN EN ISO 10993-5:2009) and were conducted by Bioserv Analytik Un 
Medizinprodukte GMBH (Rostock Germany) under GLP conditions.   
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Skin irritation assessments were conducted using healthy young female albino rabbits with a 
weight not less than 2kg (as per ISO recommendations). The rabbits were kept caged for at least 
5 days prior to the test to enable acclimatization and were immunized against myxomatosis and 
RHD. The fur on the back of the rabbits was closely clipped on both sides of the spinal column 
(10 x 15 cm) 4 hours before the test procedure was initiated. The test material (C-CAP) was 
applied directly to the clipped skin along with gauze patches that served as a control (25 x 25 
mm). The sites were then covered with a non occlusive gauze patch and then wrapped with an 
occlusive bandage for a period of 4 hours. At the end of the test, the dressings were removed and 
any residual substances were washed with warm water and the skin blown dry. The application 
sites were typically monitored at 1, 24, 48 and 72 hours after removal of the material and scored 
in terms of extent of erythema, eschar and edema formation. The results indicated that there was 
no skin irritation at any point in the course of the 72 hour observation. 
Cytotoxicity studies were conducted using 6 cm2 samples of the C-CAP material. 
Polypropylene and DMSO were used as the negative and positive control samples respectively. 
Extracts were prepared in accordance with ISO 10993-12:2012 using Dulbecco’s Modification 
of Eagle Medium with 10% fetal calf serum (DMEM-FCS). The extraction processes was run 
with gentle shaking for 24 hours at 37oC. Cell cultures were prepared using L 929 cells (ATCC 
CCL 1, NCTC clone 929, connective tissue mouse) as per recommendations in 10993-5:2009. 
Cells were grown in DMEM-FCS at 37oC and 5% CO2 in a humidified incubator. Cells were 
harvested 24 hours before determination of cytotoxicity using a trypsin / EDTA solution and re-
suspended in fresh DMEM-FCS. The cell density was adjusted to 1.75x105/mL. The wells of a 
tissue culture plate were then inoculated with 1mL of the cell suspension and incubated for 24 
hours - during which the cells formed a subconfluent monolayer. Serial dilutions of the C-CAP 
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extract were prepared to give a concentration range of 100, 66, 44, 30 and 20% using DMEM-
FCS as diluent. Each dilution extract was then tested through triplicate pipetting of 1mL aliquots 
into the respective cell culture wells (after removal of the culture medium). The well plate was 
then incubated for 24 hours prior to assessment.  The cell culture plates were examined 
microscopically and graded according to their reactivity (0: no growth inhibition/no cell lysis 
through to 4: almost complete destruction of the cell layers).  The cell layers were also 
quantitatively assessed through staining with 0.25% crystal violet, washed, dried and the cell 
bound stain extracted with 33% glacial acetic acid. The dissolved stain samples were read by 
microplate reader at 550nm. The absorbance for each sample was determined in triplicate with 
the mean value of the negative polypropylene estimated at 100% cell growth. The relative 
inhibition of cell growth (ICG) was calculated as %ICG= 100-(100 x A550 test / A550 negative 
control) whereby, in accordance with ISO 10993-5, an ICG of more than 30% is regarded as a 
cytotoxic effect. The extract solutions all fell below this threshold and along with the overall 
assessment indicated that the material did not cause any relevant toxicological or biological 
damage to the subconfluent monolayer of L929 cells under the test conditions of DIN EN ISO 
10993-5:2009. 
RESULTS AND DISCUSSION 
Scanning electron micrographs detailing the structure of a MN array (height: 350 m) cast 
from a solution of CAP without any additional components are highlighted in Figure 2A. Well 
defined peaks were obtained which were found to be stable in solutions where the pH is 
acid/neutral. Upon exposing the CAP MN array to pH 8 buffer, the needle definition deteriorates 
and gradually dissolves as indicated in the electron micrographs (B-D) recorded after 1, 3 and 5 
minute intervals respectively.  
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Figure 2.  Scanning electron micrographs of the cellulose acetate phthalate microneedles upon 
exposure to pH 8 Britton Robinson buffer. Recorded at (A) 0, (B) 1, (C) 3, and (D) 5 minutes.  
Microneedles: 200 x 200 x 350 m. 
The process was repeated using the nano carbon CAP (C-CAP) formulation and representative 
electron micrographs recorded after 1 min in pH 8 BR buffer are detailed in Figures 3A-C. The 
initial morphology of the composite needle (Figure 3A) is relatively smooth with no pronounced 
defects or granularity. The latter could have been expected given the particulate nature of the 
carbon and such features have been previously observed with palladium systems 13.  Upon being 
immersed in the pH 8 buffer, the CAP layer begins to dissolve (Figure 3B) and while the needle 
framework is retained, the outer surface begins to transform. The dissolution of the CAP leaves 
the residual carbon substructure exposing the platelet like carbon formation (Figure 3C). As the 
needles are left in contact with the buffer, dissolution of the cap continues and compromises the 
D C 
A B 
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integrity of the structure leading to sustained erosion and disappearance of the needles – akin to 
the behavior observed with the pure cap systems (Figure 2B-C) 
 
Figure 3. Scanning electron micrographs of the C-CAP microneedles before (A) and after (B) 
1 minute exposure to pH 8 Britton Robinson buffer. Dissolution of the CAP polymer leaving 
carbon platelets is highlighted in (C). Scanning electron micrographs (D,E) and computerized 
tomography (F) of  microneedles piercing of needles through de-fleshed tomato skin. 
Microneedle array: 200 x 200 x 700 m. 
The ability of the needles to pierce and retain integrity was assessed through the electron 
microscopy and computerized tomography (CT) of MN arrays puncturing tomata skin. 
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Representative images are shown in Figures 3D-F. The tomato flesh was removed from the 
cuticle in order to enable inspection of the needles post pierce with the web-like indentations on 
the skin's inner surface (Figure. 3D and 3E) characteristic of cell wall structures that remain 
strongly adherent to the cuticle. The ability to section through the microneedle array using the 
CT scans also confirmed that the needle structures were solid and free of fissures or voids. 
Cyclic voltammograms detailing the response of the carbon CAP MN array (200 x 200 x 350 
m) to ferrocyanide and ruthenium hexamine (individual solutions containing 2 mM redox 
probe, 0.1 M KCl, 50 mV/s) are detailed in Figure 4A and Figure 4B respectively. In both cases, 
well defined peaks are obtained although there is marked deviation from the ideal peak 
separations of 59 mV. This can be attributed to the composite nature of the MN array and similar 
behavior has been observed with composite Pd-polystyrene microneedle 12.  Nevertheless, the 
ability of the needles to function as viable electrochemical sensors is apparent.   
 
Figure 4.  Cyclic voltammograms detailing the response of the C-CAP microneedles to 
ferrocyanide (A) and ruthenium hexamine (B). Each redox probe present at 2 mM in 0.1 M KCl. 
Scan rate: 50 mV/s 
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ELECTROCHEMICALLY INDUCED DISSOLUTION OF CAP 
Palladium is widely used to enhance the HER process 20,21 and has been employed in the form 
of clusters and coatings with graphite 22-24, carbon nanotubes 25, graphene 26,27, Molybdenum 
nanosystems 22,28,29 and various metal nanoparticle systems 30-32 for use in fuel cell applications. 
In contrast to most metals and alloys, the dissociation of H2 molecules within Pd structures is 
facile and occurs with almost no activation barrier and serves as ideal catalyst for hydrogen 
sorption and desorption 33,34. The core approach here however, is not to utilize the hydrogen 
being produced, but rather to exploit the change in local pH that arises as a consequence of the 
electrolysis.  Given that carbon is a relatively poor substrate for the HER process, it was assumed 
that the presence of the metallic Pd on the surface would enable a much more effective response.  
A thin layer of palladium was sputtered on the C-CAP microneedles to assess whether or not the 
presence of the metal would improve the overall performance – both in terms of sensing 
application but, more importantly, as a means of enhancing the HER process which would be 
required to promote swelling of the needles as indicated in Figure 1. The influence of the Pd 
layer on the electrode response to ferrocyanide is highlighted in Figure 5A. The addition of the 
cysteine onto Pd layers was confirmed through XPS analysis and comparison of the S2p peak 
before and after modification as indicated in Figure 5B. 
The Pd layer was found to improve the electrochemical performance through increasing the 
electron transfer kinetics as indicated by the improvement in the peak definition and separation, 
however the greatest gain in performance was achieved through the further modification of the 
surface with an adsorbed cysteine layer as described by McFie(2012) and Feliciano-
Ramos(2010) and associated colleagues35,36.  The latter has been attributed to the protonated 
amino group of the cysteine improving electron transfer from the negatively charged 
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ferrocyanide36 but it must be noted that modification with 2-mercaptoethansulfonate (presenting 
a net negative charge at the interface) was equally capable of  facilitating ferrocyanide 
electrochemistry35. It is likely that the cysteine promoted electrode enhancement is through the 
removal of the surface oxides at the Pd interface35.  
     
Figure 5. A) Cyclic voltammograms comparing the response of the C-CAP and C-CAP-Pd 
microneedles to 2 mM Ferrocyanide before and after modification with palladium and cysteine. 
Scan rate: 50 mV/s. B.) XPS spectra highlighting the modification of C-CAP-Pd microneedles 
with cysteine. 
 
The responses detailed in Figure 5A highlight the benefits of employing Pd-cysteine layers for 
sensing purposes – where the microneedle array is to be used as both sensor and actuator. It must 
be noted however that the imposition of the large reducing potential necessary to initiate HER 
(and hence drug release) would result in the reduction the Pd-thiol bond leading to the desorption 
of the cysteine 37 such that the latter has little influence on kinetics of drug release. As such, the 
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cysteine modification step was omitted from the subsequent investigations of microneedle 
dissolution. Linear sweep voltammograms detailing the response of the MN arrays (C-CAP and 
C-CAP-Pd) are compared in Figure 6 under two different pH regimes. It is clear that, in both 
cases, the presence of the Pd has a dramatic impact on the relative responses.  
 
Figure 6. Linear sweep voltammograms of the unmodified and Pd coated microneedles in 
pH 3 and pH 7 Britton Robinson buffer. Scan rate: 50 mV/s. 
The next phase was to assess the ability to control the swelling or dissolution of the 
microneedles. A skin mimic assembly was constructed in which a calcium alginate gel 
containing 2 mM Ferrocyanide was prepared as previously described 12. The pH was controlled 
to ensure that the matrix itself did not lead to the dissolution of the needles. A thin layer of 
parafilm™ was then stretched over the gel to act as the skin’s stratum corneum. The modified 
microneedles were then pressed onto the parafilm layer (100 m) through simple application of 
thumb pressure with the needle tips piercing through the polymer into the underlying gel. A 
separate reference electrode (3 M NaCl Ag|AgCl) and Pt counter were then inserted through the 
parafilm to complete the cell. Ferrocyanide was included within the gel to acts as an in situ probe 
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that could be used to assess the structural integrity of the microneedle. Voltammograms were 
recorded before the application of any cathodic potential to serve as a control. It was envisaged 
that as the imposition of a cathodic potential would increase the pH and lead to the swelling or 
dissolution of the CAP binder within the core of the needle framework and, as such, the surface 
area of the needles would change. The latter could therefore be assessed through changes in the 
peak magnitude of the ferrocyanide within the gel. Thus, the ferrocyanide voltammograms were 
recorded before and after each cathodic step. Cyclic voltammograms detailing the response of 
the MN array within the alginate layer before and after the imposition of a potential of -2 V are 
shown in Figure 7. Before the cathodic potential is applied, the voltammetric response of the MN 
array to ferrocyanide is consistent with that observed in Figure 5A.  
 
Figure 7. Cyclic voltammograms detailing the response of the C-CAP-Pd microneedles to 2 mM 
Ferrocyanide before and after holding the electrode at -2 V for given time periods. 
Scan rate: 50 mV/s. 
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The voltammetric profile changes dramatically upon stimulating hydrogen evolution with a 
loss of definition. The latter can be attributed to increased resistance within the bulk of the 
needle structure as a consequence of the binder swelling and increasing the spatial separation 
between the carbon particles. The swelling and dissolution of the MN was confirmed through 
placing the array within pH 6 Britton Robinson buffer (without a barrier layer) and examining 
the needle morphology after various periods of imposing the cathodic potential (-1 V and -2 V). 
Electron micrographs comparing needle integrity before and after the onset of hydrogen 
evolution are detailed in Figures 8A-C. The electron micrographs highlight the gradual 
dissolution of the microneedle structure as the electrode is held at varying potentials (-1 V and -2 
V) for a period of 30 s. The dissolution of the CAP polymer is noticeable at -1 V with the 
structure of the needle being analogous to that observed in Figure 3B. The application of -2 V 
however leads to the near complete removal of the needle after 30 s. However, it is clear from 
inspecting the cyclic voltammograms (Figure 7) that the resistance increases dramatically upon 
imposing the reducing potential for very short periods indicating that swelling occurs relatively 
readily but complete dissolution (and degradation of the needle bulk) requires much more 
forceful conditions. The continued response observed in Figure 7 after the apparent destruction 
of the needle (as indicated in Figure 8C) is attributed to the continuing electroactivity of the base 
plate. 
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Figure 8.  Scanning electron micrographs of the C-CAP-Pd microneedles after poising the 
electrode at a  reducing potential. A) Open circuit. B) -1 V for 30 s. C) -2 V for 30 s. 
Microneedle: 200 x 200 x 700 m. 
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ELECTROCHEMICAL RELEASE OF MODEL DRUG 
 
The efficacy of the electrochemical release method was assessed with a model drug using a 
gelatin matrix to mimic transport into the skin. The pH of the gelatin was adjusted to pH 4.02 
which would prevent the dissolution of the CAP and retain the integrity of the composite 
microneedle assembly. Toluidine Blue O (TBO) was chosen as the model drug agent as it could 
be easily monitored through visual inspection through a blue coloration (max 630 nm) and 
could be readily incorporated into the C-CAP formulation.  The C-CAP was added to a solution 
of TBO (5%) in cyclohexanone and stirred until a viscous solution was achieved.  It was 
envisaged that the imposition of the reducing potential at the microneedle array would initiate the 
HER process and lead to an increase in the local pH. This would induce the dissolution of the 
CAP resulting in the release of TBO into the gelatin. To ensure the TBO was released 
exclusively from the needles, the MN array was first pierced through a layer of parafilm, which 
acted as a skin mimic, before being placed in the gel in order to separate the baseplate from the 
gelatin. The TBO containing MN were washed in acid to remove extraneous TBO and then 
pierced into the gelatin layer and left to sit. No blue coloration was observed and confirmed that 
the TBO was entrapped within the MN structure. The effect of imposing the reducing potential is 
highlighted in Figure 9 where the blue coloration associated with TBO can be seen to develop 
with duration of the HER electrolysis. 
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Figure 9.  A CAP-C -Pd MN array loaded with TBO and pierced into gelatin (pH 4.02). The 
imposition of a potential of -2V over a period of 100s is shown to effect the release of TBO (blue 
coloration). Microneedle: 200 x 200 x 700 m 
 
The release of TBO within the gelatin was induced through the application of a large reducing 
potential (-2V) which has the effect of rapidly changing the pH at the electrode surface and 
speeds the dissolution of the CAP component. The prime disadvantage of this approach relates to 
the fact that the integrity of the needles is rapidly compromised (Figure 8C). A more subtle 
approach, involving less negative potentials, can also be used (as previously highlighted in 
Figure 8B). The release of the TBO model drug was further investigated through employing a -
1V release step applied repetitively over a period of 40 minutes in pH 5 buffer. The microneedle 
array was held for 3 minutes at the reducing potential and thereafter the solution was sampled 
and analysed using conventional colorimetry (TBO max 632 nm;  = 30,000 M-1 cm-1  38). A 
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control microneedle array containing TBO was left in contact with the buffer without any applied 
potential and the results are detailed in Figure 10A. In the absence of an applied potential, there 
is effectively no release of TBO whereas, the repeated application of -1V results in sustained 
release of the model drug. The typical yield per cycle is highlighted in Figure 10B and increases 
with each cycle before falling dramatically to zero – at which point the needle has effectively 
dissolved. The yield of drug fall within the nanomole region as expected given the relatively low 
capacity of the needles.  
 
 
Figure 10.  The effect of repetitive applying a potential (-1V, 300s) on the release of Toluidine 
Blue into pH 5 buffer (A) and the corresponding yield per cycle (B)  
Microneedle: 200 x 200 x 700 m 
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The micro-molding technique clearly provides a facile means of producing high quality 
microneedles which, through judicious selection of the casting components, could be applied to a 
wealth of sensing and drug delivery applications 1-9. The nano-carbon systems are conductive 
and exhibit reasonable electrochemical properties which could be harnessed in analytical 
scenarios. The modification with Pd is easily achieved through employing standard techniques 
used for coating SEM samples yet the presence of the metal can provide significant enhancement 
to the voltammetric performance. The main impact of the work described however relates to the 
ability to control the integrity of the microneedle through controlling the potential applied at the 
needles themselves. It is easy to envisage the incorporation of a suitable drug candidate within 
the carbon-CAP matrix at the time of casting. Drug yield will however be an issue, as it is for 
many microneedle systems, and it is inevitable that the system proposed here would only be 
viable for low yield - high potency agents 1-9. The imposition of the reducing potential, while 
necessary to induce swelling, could also, in principle lead to the reduction of functional groups 
within the drug – such as nitro groups – and care would be required to ensure there were no 
inadvertent modifications to the therapeutic agent as a consequence of the release mechanism. 
The possibility of fragmentation and the loss of carbon/Pd particulates must also be considered. 
It must be noted however that, providing the needles are sufficiently shallow, residual needle 
fragments are liable to be expunged from the skin through normal skin turnover in the outer 
layers which would normally occur over a period of weeks 39. The biocompatibility studies of the 
C-CAP material provide some positive insights into the potential use of the material with no 
apparent skin irritation nor cytotoxicity however these need to be viewed with some caution – 
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particularly where the devices may be used for long term applications where sensitisation may 
occur. 
 
CONCLUSIONS  
The electrode potentials used in this work to effect the swelling and dissolution are 
significantly large and have been selected on the basis of enabling gross characteristics to be 
observed with relative ease for the purpose of confirming proof of concept. The use of less 
negative potentials would necessarily reduce the degree of pH modification and thus, rather than 
having fairly rapid release, could enable a much more metered dosing without the dramatic 
deterioration of the needle structure. This would mitigate against issues associated with the loss 
of nano carbon/Pd particles into the skin. The approach presented highlights a new route through 
which microneedle structure could be controlled in situ and thereby offer alternative means of 
controlling dosage.  
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